đź’¨ Abstract
On May 2025, Metagenomi Inc. (MGX) reported a first-quarter loss of $25 million, or 68 cents per share, missing Wall Street's estimates of a 62 cents per share loss. The genetic medicines company based in Emeryville, California, reported revenue of $4.1 million for the quarter.
Courtesy: wtop.com
Suggested
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -
Gobierno de Trump recorta otros US$ 450 millones en subvenciones a Harvard y se suman a los US$ 2.200 millones ya congelados -
BYU promotes Brian Santiago to replace longtime athletic director Tom Holmoe -
California approves State Farm’s request for 17% premium increase for homeowners -
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -
MLB reinstates Pete Rose and Shoeless Joe Jackson, making them Hall of Fame eligible -
Indexes___________________________Close_____Dly Chg___Week Chg__Ytd Chg -